Risk factors for immune-related adverse effects during CPI therapy in patients with head and neck malignancies – a single center study

Risk factors for immune-related adverse effects during CPI therapy in patients with head and neck malignancies – a single center study

IntroductionCheckpoint inhibitors, such as PD1 inhibitors, represent an important pillar in the therapy of advanced malignancies of the head and neck region. The most relevant complications are immune-related adverse effects (irAEs), which represent an immense burden for patients. Currently, no suff...

Full description

Bibliographic Details
Main Authors: Frederic Jungbauer, Annette Affolter, Christoph Brochhausen, Anne Lammert, Sonja Ludwig, Kirsten Merx, Nicole Rotter, Lena Huber
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
HNSCC (head and neck squamous cell carcinoma)
HNC (head and neck cancer)
checkpoint inhibition
irAE
irAE diagnostic approach
PD-L1
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1287178/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1287178/full

Similar Items